SeubertSSeubertARumpfKWKihehA porphyria cutanea tanda-like distribution pattern of porphyrins in plasma, huemodialysate, hemofiltrate and urine of patients on chronic hemodialysis. J Invest Dermatol1985; 85: 107–109.
GoldbergAMcCollKELMooreMR. Alcohol and porphyria. Lancet1982; i: 1354–5.
9.
Poh-FitzpatrickMB. Pathogenesis and treatment of photocutaneous manifestations of the porphyrias. Semin Liver Dis1982; 2: 164–76.
10.
ElderGH. Enzymatic defects in porphyria: An overview. Semin Liver Dis1982; 2: 87–99.
11.
ElderGH. Metabolic abnormalities in the porphyrias. Seminars Dermatol1986; 5: 88–98.
12.
SweeneyGD. The uroporphyrinogen decarboxylase deficiency diseases. Clin Biochem1986; 19: 3–15.
13.
ElderGHRobertsAGDe SalamancaRE. Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects. Clin Biochem1989; 22: 163–8.
14.
FujitaHSassaSTobackACKappasA.Immunochemical study of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria. J Clin Invest1987; 79: 1533–7.
DeybachJ-C.Enzymatic studies on lymphocytes in human porphyrias. In: NordmannY, ed. Porphyrins and Porphyria. Paris: INSERM-John Libby, 1986; 163–74.
18.
KordacVMartasekPZemanJIncreased erythrocyte protoporphyrin in homozygous variegate porphyria. Photodermatol1985; 2: 257–9.
19.
KushnerJPPimstoneNRKjeldsbergCRCongenital erythropoietic porphyria, diminished activity of uroporphyrinogen decarboxylase and dyserythropoiesis. Blood1982; 59: 725–37.
20.
DossMMullerWA. Acute lead poisoning in inherited porphobilinogen synthase deficiency. Blut1982; 45: 131–9.
21.
DayRSEalesLMeissnerD.Coexistent variegate porphyria and porphyria cutanea tarda. N Eng J Med1982; 307: 36–41.
22.
QadiriMRChurchSEMcCollKELChester porphyria—a clinical study of a new form of acute porphyria. Br Med J1986; 292: 455–9.
23.
DossM.New dual form of porphyria. Lancet1988; i: 945–6.
24.
McCollKELGoldbergA.Abnormal porphyrin metabolism in diseases other than porphyria. Clin Haematol1980; 9: 427–44.
25.
LindbladBLindstedtSSteenG.On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci1977; 74: 4641–5.
26.
RomsloIBrunASandbergSSideroblastic anaemia with markedly increased free erythrocyte protoporphyrin without dermal photosensitivity. Blood1982; 59: 628–33.
27.
BeukeveldGJJWolthersBGvan SaeneJJMPatterns of porphyrin excretion in faeces as determined by liquid chromatography: Reference values and the effect of flora suppression. Clin Chem1987; 33: 2164–70.
28.
MooreMR. Laboratory investigation of disturbance of porphyrin metabolism. Assoc Clin Pathol Broadsheet1983; 109: 1–15.
29.
LimCKRideoutJMPetersTJ. Pseudoporphyria associated with consumption of brewer's yeast. Br Med J1984; 288: 1640.
LamonTWithTKRedemarAG. The Hoesch test: Bedside screening for urinary porphobilinogen in patients with suspected porphyria. Clin Chem1974; 20: 1430–8.
35.
MauzerallDGranickS.The occurrence and determination of δ-amino-levulinic acid and porphobilinogen in urine. J Biol Chem1956; 219: 435–46.
36.
SmithKM. Porphyrins and Metalloporphyrins. Amsterdam: Elsevier, 1975.
37.
DeaconAC. Performance of screening tests for porphyria. Ann Clin Biochem1988; 25: 392–7.
38.
JonesKGSweeneyGD. Measurement of urine porphyrins and porphyrinogens. Biochem Med1976; 15: 223–32.
39.
JonesKGSweeneyGD. Quantitation of urinary porphyrins by use of second derivative spectroscopy. Clin Chem1979; 25: 71–4.
40.
PoulosVLockwoodWH, Direct spectrofluorometric determination of porphyrin in diluted urine. Int J Biochem1980; 12: 1051–2.
41.
WesterlundJPudekMSchreiberWE. A rapid and accurate spectro-fluorometric method for quantification and screening of urinary porphyrins. Clin Chem1988; 34: 345–51.
42.
ValcarcelMHensAGRubioSPetidierA.Direct quantification of coproporphyrins and uroporphyrins in urine by derivative synchronous fluorescence spectroscopy. Clin Chem1987; 33: 1826–31.
43.
WithTKPedersenJS. Ion exchange analysis of porphyrins in urine. Scand J Clin Lab Invest1978; 38: 279–84.
44.
AACBRecommended Porphyrin Methods for Peripheral LaboratoriesAustralia: Australian Association of Clinical Biochemists, 1985.
45.
RimingtonC.Quantitative determination of porphobilinogen and porphyrins in urine and porphyrins in faeces and erythrocytes. Assoc Clin Pathol Broadsheet1971; No. 70.
46.
EalesLLeveyMJSweeneyGD. The place of screening tests and quantiative investigations in the diagnosis of the porphyrias. S Afr Med J1966; 40: 63–71.
47.
RimingtonCCrippsDJ. Biochemical and fluorescence-microscopy screening tests for erythropoietic protoporphyria. Lancet1965; i: 624–6.
48.
PiomelliS.Free erythrocyte porphyrin in the detection of undue absorption of lead and of iron deficiency. Clin Chem1977; 23: 264–9.
49.
GardenJSMitchellDGJacksonKWAldonsKM. Improved ethanol extraction procedure for determining zinc protoporphyrin in whole blood. Clin Chem1977; 23: 1585–9.
50.
Poh-FitzpatrickMB. A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol1980; 116: 543–7.
51.
RossiECurnowDH. Porphyrins. In: LimCK, ed. Hplc of Small Molecules: a Practical Approach. Oxford and Washington, DC: IRL Press, 1986; 261–303.
52.
RimingtonCLockwoodWHBelcherRV. The excretion of porphyrin peptide conjugates in variegate porphyria. Clin Sci1968; 35: 211–47.
53.
SmithSG. The use of thin layer chromatography in the separation of free porphyrins and porphyrin methyl esters. Br J Dermatol1978; 93: 291–5.
54.
KotalPJirsaMMartasekPKordacV.Solid phase extraction and isocratic separation of urinary porphyrins by HPLC. Biomed Chromatogr1986; 1: 159–62.
55.
LimCKPetersTJ. Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin Chem Acta1984; 139: 55–63.
56.
ElderGH. Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of isocoproporphyrin in faeces. J Clin Path1975; 28: 601–7.
57.
TaddeiniLKayITWatsonCJ. Inhibition of the Ehrlich's reaction of porphobilinogen by indican and related compounds. Clin Chim Acta1962; 7: 890–1.
58.
PierachCAWiernerMKCardinalRARed blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria. JAMA1987; 257: 60–1.
59.
BloomerJR. The liver in protoporphyria. Hepatology1988; 8: 402–7.
60.
HarberLCBickersDR. Porphyria and pseudoporphyria. J Invest Dermatol1984; 82: 207–9.
DesnickRJOstasiewiczLTischlerPAcute intermittent porphyria: Characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of non-catalytic enzyme intermediates stabilized by bound protein. J Clin Invest1985; 76: 865–74.
63.
LamonJMFrykholmBGTschudyDP. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthase. J Med Genet1979; 16: 134–9.
64.
Bonaiti-PellieCPhungLNordmannY.Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: A Gayesian approach. Am J Med Genet1984; 19: 755–62.
65.
McCollKELMooreMRThompsonGGGoldbergA.Screening for latent acute intermittent porphyria: The value of measuring both leucocyte deltaaminolaevulinic acid synthase and erythrocyte uroporphyringoen-I-synthetase activities. J Med Genet1982; 19: 271–6.
66.
LlewellynDHElderGHKalshekerNADNA polymorphism of human porphobilinogen deaminase gene in acute intermittent porphyria. Lancet1987; ii: 706–8.
67.
LeeJ-SAnvretMLindstenJDNA polymorphisms within the porphobilinogen deaminase gene in two Swedish families with acute intermittent porphyria. Hum Genet1988; 79: 379–81.
68.
GrandchampBPicatCMignotteVTissue specific splicing mutation in acute intermittent porphyria. Proc Natl Acad Sci USA1989; 86: 661–4.
69.
BloomerJRBonkowskyHLEbertPSMahoneyMJ. Inheritance in protoporphyria. Lancet1976; ii: 226–8.
70.
WentLNKlasenEC. Genetic aspects of erythropoietic protoporphyria. Ann Hum Genet1984; 48: 105–17.
71.
TishlerPVWoodwardBO'ConnorJHigh prevalence of acute intermittent porphyria in a psychiatric patient population. Am J Psychiatry1985; 142: 1430–6.